On the public citation graph
Identifying Patients with Mild-to-Moderate COPD Who Require Intensified Initial Treatment to Control Clinically Important Deterioration
0 signed · 36 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1007/s11606-009-0907-yopenalex-snapshot
The Effects of Smoking Cessation on the Risk of Chronic Obstructive Pulmonary Disease Exacerbations
inferredcites →https://doi.org/10.1016/j.clnu.2005.01.005openalex-snapshot
Nutritional support and quality of life in stable chronic obstructive pulmonary disease (COPD) patients
inferredcites →https://doi.org/10.1016/j.vaccine.2008.05.037openalex-snapshot
Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease
inferredcites →https://doi.org/10.1016/s0140-6736(05)67100-0openalex-snapshot
Roflumilast—an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial
inferredcites →https://doi.org/10.1038/s41467-024-51079-1openalex-snapshot
Effect of high-dose N-acetylcysteine on exacerbations and lung function in patients with mild-to-moderate COPD: a double-blind, parallel group, multicentre randomised clinical trial
inferredcites →https://doi.org/10.1056/nejmoa0909883openalex-snapshot
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
inferredcites →https://doi.org/10.1056/nejmoa1105482openalex-snapshot
Changes in Forced Expiratory Volume in 1 Second over Time in COPD
inferredcites →https://doi.org/10.1056/nejmoa1516385openalex-snapshot
Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD
inferredcites →https://doi.org/10.1056/nejmoa1700228openalex-snapshot
Tiotropium in Early-Stage Chronic Obstructive Pulmonary Disease
inferredcites →https://doi.org/10.1056/nejmoa1708208openalex-snapshot
Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease
inferredcites →https://doi.org/10.1056/nejmoa1713901openalex-snapshot
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
inferredcites →https://doi.org/10.1056/nejmoa1916046openalex-snapshot
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD
inferredcites →https://doi.org/10.1081/copd-200053377openalex-snapshot
Minimal Clinically Important Differences in COPD Lung Function
inferredcites →https://doi.org/10.1136/bmjopen-2013-003991openalex-snapshot
Early intervention with tiotropium in Chinese patients with GOLD stages I–II chronic obstructive pulmonary disease (Tie-COPD): study protocol for a multicentre, double-blinded, randomised, controlled trial
inferredcites →https://doi.org/10.1136/thoraxjnl-2016-209846openalex-snapshot
Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts
inferredcites →https://doi.org/10.1136/thx.2003.006502openalex-snapshot
1-Antitrypsin deficiency {middle dot} 2: Genetic aspects of 1-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk
inferredcites →https://doi.org/10.1136/thx.2005.052241openalex-snapshot
Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA Cohort Study
inferredcites →https://doi.org/10.1164/rccm.201404-0720ocopenalex-snapshot
FEV1 Decline in Patients with Chronic Obstructive Pulmonary Disease Associated with Biomass Exposure
inferredcites →https://doi.org/10.1164/rccm.202303-0450ocopenalex-snapshot
FEV1/FVC Severity Stages for Chronic Obstructive Pulmonary Disease
inferredcites →https://doi.org/10.1183/09031936.00162414openalex-snapshot
Eosinophilic inflammation in COPD: prevalence and clinical characteristics
inferredcites →https://doi.org/10.1183/13993003.00239-2023openalex-snapshot
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
inferredcites →https://doi.org/10.1183/13993003.congress-2021.pa3193openalex-snapshot
Late Breaking Abstract - Estimating the relationship between environmental exposures and acute exacerbations of COPD
inferredcites →https://doi.org/10.1183/23120541.00047-2018openalex-snapshot
Preventing clinically important deterioration with single-inhaler triple therapy in COPD
inferredcites →https://doi.org/10.1186/s12889-024-17686-9openalex-snapshot
Estimating the global prevalence of chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis
inferredcites →https://doi.org/10.1186/s12931-020-01387-zopenalex-snapshot
Measuring disease activity in COPD: is clinically important deterioration the answer?
inferredcites →https://doi.org/10.1186/s13561-021-00329-9openalex-snapshot
Cost analysis of chronic obstructive pulmonary disease (COPD): a systematic review
inferredcites →https://doi.org/10.1378/chest.117.3.672openalex-snapshot
Nutritional Support for Individuals With COPD
inferredcites →https://doi.org/10.1378/chest.125.6.2011openalex-snapshot
Acute Respiratory Illness in Patients With COPD and the Effectiveness of Influenza Vaccination
inferredcites →https://doi.org/10.1513/pats.2306030openalex-snapshot
Role of Viruses in Exacerbations of Chronic Obstructive Pulmonary Disease
inferredcites →https://doi.org/10.20982/tqmp.14.2.p099openalex-snapshot
User-friendly Bayesian regression modeling: A tutorial with rstanarm and shinystan
inferredcites →https://doi.org/10.2147/copd.s307160openalex-snapshot
A Dose-Ranging Study of the Novel Inhaled Dual PDE 3 and 4 Inhibitor Ensifentrine in Patients with COPD Receiving Maintenance Tiotropium Therapy
inferredcites →https://doi.org/10.33590/emjrespir/10314956openalex-snapshot
Inhaled Ambient Particulate Matter and Lung Health Burden
inferredcites →https://doi.org/10.3389/fphys.2015.00294openalex-snapshot
Fine particulate matter in acute exacerbation of COPD
inferredcites →https://doi.org/10.3390/ijerph16010088openalex-snapshot
Direct Hospitalization Cost of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Vietnam
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.